EQUITY (Tables)

12 Months Ended

Dec. 31, 2021

Equity [Abstract]

SCHEDULE OF ISSUANCE OF WARRANTS TO PURCHASE COMMON STOCK

	Number of underlying Common stock		Weighted average exercise price
Series E Warrants		198,159	$	27.000
Series F Warrants		433,878	$	7.425
Series G Warrants		1,092,344	$	10.230
Underwriter Warrants		18,277	$	7.425
Other warrants		51,325	$	225.000 and above
Total Warrants		1,793,983	$

SCHEDULE OF STOCK OPTIONS GRANTED

5) The following table summarizes information about stock options granted to employees:

	Year ended December 31
	2021					2020
	Number of options			Weighted average exercise price		Number of options			Weighted average exercise price
Outstanding - beginning of period		91,692			6.20		-		$	-
Granted		205,223			4.90		92,007			6.20
Forfeited		(7,507	)		5.69		(315	)		5.85
Outstanding-end of period		289,408		$	5.29		91,692		$	6.20
Exercisable at the end of the period		28,360			6.26		-			-

6) The following table summarizes information about stock options granted to non-employees:

	Year ended December 31
	2021				2020
	Number of options		Weighted average exercise price		Number of options		Weighted average exercise price
Outstanding - beginning of period		-		-		-		-
Granted		20,002		6.90		-		-
Forfeited		-		-		-		-
Exercised		-				-		-
Outstanding - end of period		20,002		6.90		-		-
Exercisable at the end of the period		-		-		-		-

SCHEDULE OF RESTRICTED STOCK GRANTED TO EMPLOYEES

7) The following table summarizes information about restricted stock granted to employees:

	Year ended December 31
	2021			2020
	Number of restricted stock
Outstanding - beginning of period		185,725			4,642
Reverse Split Adjustments		59			-
Granted		419,943			185,461
Forfeited		(20,822	)		(3,717	)
Vested		(57,237	)		(661	)
Outstanding - end of period		527,668			185,725

SCHEDULE OF RESTRICTED STOCK UNIT GRANTED TO EMPLOYEES

8) The following table summarizes information about Restricted Stock Units granted to employees:

	Year ended December 31
	2021		2020
	Number of restricted stock units
Outstanding - beginning of period		90,511		11,000
Granted		146,567		90,511
Forfeited		-		-
Vested		-		(11,000	)
Outstanding - end of period		237,078		90,511

SCHEDULE OF ADDITIONAL INFORMATION ABOUT ALL OPTIONS OUTSTANDING AND EXERCISABLE

9) The following table provides additional information about all options outstanding and exercisable:

		Outstanding as of December 31, 2021
Exercise price		Options outstanding		Weighted average remaining contractual life (years)		Options exercisable
$	3.89-4.12		146,539		9.81		-
$	4.95-10.05		158,819		8.99		27,009
$	16.50		4,052		8.01		1,351
			309,410		9.37		28,361

SCHEDULE OF FAIR VALUE OF OPTIONS GRANTED TO EMPLOYEES

	Year ended December 31
	2021		2020
	Number of restricted stock
Expected life	5.5-6.5 years		5.5-6.5 years
Risk-free interest rates	0.59%-1.40	%	0.32%-0.42	%
Volatility	129.11%-136.78	%	124.53%-136.66	%
Dividend yield	-		-

SCHEDULE OF ALLOCATION OF TOTAL SHARE-BASED COMPENSATION EXPENSE

	Year ended December 31
	2021		2020
	($ in thousands)
Cost of revenues	$	49	$	22
Research and development		64		29
Sales and marketing		182		32
General and administrative		1,281		523
	$	1,576	$	606